Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$25.16 -0.13 (-0.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

Arcutis Biotherapeutics (ARQT) Interest & Investment Income (2025 - 2026)

Updated

Arcutis Biotherapeutics' Interest & Investment Income was $2.28 million in Q2 2026, up 9.8% from $2.08 million a year earlier and up 0.2% from the prior quarter.

Analysis

Arcutis Biotherapeutics (ARQT) Interest & Investment Income (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Arcutis Biotherapeutics' Interest & Investment Income was $9.17 million through Jun 30, 2026; for FY2025, it came in at $8.9 million, down 44.8% from FY2024.

  • In earlier years, Interest & Investment Income was $16.13 million in FY2024 (+28.8%) and $12.52 million in FY2023.
  • The Q2 2026 figure marks the highest quarterly Interest & Investment Income since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Arcutis Biotherapeutics 3.16 Bn 2.44 Bn 118.92 Mn 2.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.28 Mn
Mar 31, 2026 2.28 Mn
Jun 30, 2025 2.08 Mn
Mar 31, 2025 2.54 Mn
API Access

Arcutis Biotherapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ARQT&period=max&api_key=YOUR_API_KEY